The PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial is 100% enrolled; expect to report topline data for this cohort in late Q1 2025 or Q2 2025Approximately $264 million in cash, cash equivalen ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today ann ...

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

The NHS is launching a search for nearly 150,000 volunteers to take part in a series of research trials that could transform cancer treatment. Three cancer projects have been selected as part of the ...

WESTLAKE VILLAGE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the third quarter ...

The former head of France's domestic intelligence agency went on trial on Wednesday on charges of using his security contacts ...

A “prolific” people smuggler has been convicted after co-ordinating a £1.5m operation to transport migrants across the ...

The former head of France’s domestic intelligence agency stands trial accused of spying for Bernard Arnault’s luxury conglomerate, carrying out covert surveillance of a top critic and helping to ...

Spy-accused former soldier Daniel Khalife had a 30-minute phone conversation with an Iranian agent while posted at a US army base, a court has heard. The three calls “rekindled” Iran’s interest in ...

French court of appeal rules that the Swiss art dealer and his business partner Olivier Thomas should face charges relating ...

A drug-eluting contact lens that uses 3D printing technology can improve IOP and treatment compliance for patients with glaucoma.